Literature DB >> 8058567

The pathologist and the residual tumor (R) classification.

P Hermanek1, C Wittekind.   

Abstract

The R classification, adopted in 1987 by the UICC, denotes absence or presence of residual tumor after treatment. Residual tumor may be localized in the area of the primary tumor and/or as distant metastases. R0 corresponds to resection for cure or complete remission. R1 to microscopic residual tumor, R2 to macroscopic residual tumor. The R classification takes into account clinical and pathological findings. A reliable classification requires the pathological examination of resection margins. The R classification has considerable clinical significance, particularly being a strong predictor of prognosis. General and specific procedures for performing pathological R classification on resection specimens of different organs will be described. New methods in R classification comprise imprint cytology, cytolocial examination of ascites, examination of bone marrow biopsy. The importance of these methods will have to be established in the future.

Entities:  

Mesh:

Year:  1994        PMID: 8058567     DOI: 10.1016/S0344-0338(11)80700-4

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  35 in total

1.  [Tumor classifications].

Authors:  C Wittekind; I Tischoff
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

2.  Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Authors:  Yan Zhu; Mei-Dong Xu; Chen Xu; Xiao-Cen Zhang; Shi-Yao Chen; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Tian-Yin Chen; Jia-Xin Xu; Li-Qing Yao; Quan-Lin Li; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

3.  [Residual cancer or not residual cancer--that is the question].

Authors:  P Meister
Journal:  Pathologe       Date:  2007-07       Impact factor: 1.011

4.  The first European Union Network of Excellence for Gastric Cancer conference, Rome, Italy, April 2008.

Authors:  William Allum; Alfredo Garofalo; Maurizio Degiuli; Christoph Schuhmacher
Journal:  Gastric Cancer       Date:  2009       Impact factor: 7.370

5.  Impact of residual disease after "unplanned excision" of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution.

Authors:  G Bianchi; A Sambri; S Cammelli; A Galuppi; A Cortesi; A Righi; E Caldari; S Ferrari; D Donati
Journal:  Musculoskelet Surg       Date:  2017-04-25

Review 6.  [Pitfalls in the classification of liver tumors].

Authors:  C Wittekind
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

7.  Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Authors:  Arsen Osipov; Jason Naziri; Andrew Hendifar; Deepti Dhall; Joanne K Rutgers; Shefali Chopra; Quanlin Li; Mourad Tighiouart; Alagappan Annamalai; Nicholas N Nissen; Richard Tuli
Journal:  J Gastrointest Oncol       Date:  2016-04

8.  Skeletonizing en bloc esophagectomy for cancer.

Authors:  J M Collard; J B Otte; R Fiasse; P F Laterre; M De Kock; J Longueville; D Glineur; R Romagnoli; M Reynaert; P J Kestens
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 9.  Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.

Authors:  B Rau; P Wust; P Hohenberger; J Löffel; M Hünerbein; C Below; J Gellermann; A Speidel; T Vogl; H Riess; R Felix; P M Schlag
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

Review 10.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.